Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models

Gallbladder cancer is a highly aggressive malignancy with poor sensitivity to postoperative radiotherapy or chemotherapy; therefore, the development of individualized treatment strategies is paramount to improve patient outcomes. Both patient-derived tumor xenograft (PDX) and patient-derived tumor o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Dengxu, An, Jiaze, Gong, Miaomiao, Wang, Huihui, Li, Han, Meng, Han, Zhang, Caiqin, Zhao, Yong, Ge, Xu, Shi, Changhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795198/
https://www.ncbi.nlm.nih.gov/pubmed/36591461
http://dx.doi.org/10.3389/fonc.2022.1043479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795198/
https://www.ncbi.nlm.nih.gov/pubmed/36591461
http://dx.doi.org/10.3389/fonc.2022.1043479

Ejemplares similares